Gumma is a specific pathological process, the essence of which lies in the formation of gummatous lesions characterized by necrotic changes in tissue, often with granuloma phenomena. The disease belongs to the group of syphilitic processes and can be localized in various organs and systems, including the skin, mucous membranes, internal organs and bone tissue. Gumma is one of the late manifestations of syphilis, which usually occurs at the stage of tertiary syphilis. The development of gummas occurs gradually, often a significant time after infection, which complicates diagnosis and leads to complications if the disease is not properly diagnosed and treated.
History of the disease and interesting historical facts
The history of gumma is inextricably linked with the history of syphilis in general. Syphilis, and therefore gumma, is believed to have been first described in Europe in the late 15th century. The name "syphilis" comes from the name of Pastor Syphilis, the hero of the poem of the same name by the Italian physician Francesco Malpighi. For centuries, gumma remained an invariable companion of this infection, recording the tragic consequences of ineffective treatment and insufficient knowledge about the nature of the disease. An interesting fact is that in different historical eras, gumma was explained by various theories: from divine punishment to inadequate medical care. Its widespread use among patients in the 19th century led to an emphasis on gummas in scientific circles, which contributed to the further development of medical science.
Epidemiology
The epidemiology of gumma varies depending on socio-economic factors, the level of access to health care and the prevalence of syphilis in the regions. According to statistics, more than 20 million cases of active syphilis have been registered in the world, of which a third is the tertiary form with gummatous lesions. In the vast majority of cases, gumma is diagnosed in men, most often at the age of 30-49 years. It is worth noting that the epidemiological situation in different countries differs significantly, which is due to historical and cultural traditions of combating venereal diseases.
With adequate diagnostics to monitor and control the disease, a significant reduction in the incidence of gummatous lesions can be achieved.
Genetic predisposition to this disease
To date, genetic predisposition to gumma has not been studied in depth enough. However, some studies indicate a possible influence of certain genes associated with the immune response to infectious agents on the development of gummas. In particular, genes associated with the production of interleukins (IL-6, IL-10) and the progression of inflammatory reactions may affect the risk of developing pathology. The natural stable reaction of the immune system to Treponema pallidum, the causative agent of syphilis, is also being studied, but the nature of gumma is multifactorial, and exclusively genetic factors cannot explain the development of this disease.
Risk factors for the development of this disease
Risk factors that contribute to the development of gumma can be divided into several categories:
- Physical factors:
- Age (more common in men aged 30-49 years);
- Gender (higher predisposition in males);
- Chemical factors:
- Drug and alcohol use;
- Ineffective or inadequate treatment of syphilis;
- Social factors:
- Low level of education;
- Lack of access to health services;
- Living in disadvantaged areas.
Insufficient information about diseases, high risks of social discrimination, and inappropriate treatment also play an important role in changing the incidence rate.
Diagnosis of this disease
Gumma diagnostics begins with an assessment of clinical symptoms, such as the appearance of deep inflammatory lesions, fistulas, and pain in the affected tissues. The main symptoms include:
- Formation of gummatous nodes under the skin;
- Pathological changes in the mucous membranes;
- Pain syndromes in the area of affected organs;
- Profuse discharge from fistulas.
Laboratory tests include serologic tests for syphilis (RPR, VDRL) and histologic examination of tissue samples to detect characteristic changes. Radiologic examinations allow assessment of possible bone lesions, which are sometimes present in the patient.
Other diagnostics include ultrasound, computed tomography if necessary to assess the condition of the internal organs. Differential diagnosis should be made with other granulomatous diseases, such as sarcoidosis and tuberculosis.
Treatment
Treatment of gumma involves a comprehensive approach that considers both symptomatic and etiologic therapy. The main treatment is based on the use of antibiotics, such as penicillin, which is the standard treatment for syphilis. Pharmacological treatment is carried out in long courses, taking into account the stage of the disease and the patient's condition.
Surgical treatment may be necessary in cases where the gumma reaches significant sizes, causes compression of surrounding tissues or causes fistulas. Such interventions are aimed at eliminating complications and improving the patient's quality of life. The use of immunomodulatory agents, such as interferons, is also possible to improve the general condition.
List of medications used to treat this disease
- Penicillin G;
- Doxycycline;
- Ceftriaxone;
- Azithromycin;
- Tetracycline;
- Immunomodulatory drugs (interferons).
Each remedy must be prescribed by a doctor, taking into account the individual characteristics of the patient.
Disease monitoring
Monitoring the condition of a patient with gumma includes regular examinations to assess the effectiveness of the treatment, as well as identifying possible relapses or complications. Control stages usually include:
- Serological tests for syphilis monitoring;
- Examination of the affected area;
- General blood and urine tests;
- Consultation with dermatologists and other specialists.
The prognosis of the disease with adequate treatment is usually favorable, but complications such as inflammation of adjacent organs, gangrene and systemic reactions are possible.
Age-related features of the disease
In older patients, gumma may develop faster due to a weakened immune system, making them more vulnerable to infections. In the younger generation, gumma is more often diagnosed in an associative context with the consequences of unprotected sexual intercourse and drug addiction. In childhood, gumma is usually not observed, but cases associated with perinatal transmission of infection are possible. The prognosis also varies depending on age: young patients have a higher probability of complete recovery with timely treatment.
Questions and Answers
- How to prevent gumma development? Prevention consists of preventing syphilis: using condoms, regular medical examinations and tests for infectious diseases.
- What are the differences between gummas and other skin growths? Gummas have characteristic features such as softness to the touch, severe inflammation and a tendency to form fistulas, which distinguish them from other dermatological pathologies.
- Can gumma lead to serious complications? Yes, gummas can lead to serious complications if left untreated, including systemic reactions and bone inflammation.
- How often should follow-up examinations be done after treatment? It is recommended to perform follow-up examinations every 3-6 months during the first year and annually thereafter if the patient's condition is stable.
- Can gumma develop into cancer? Gumma is not a malignant formation, but chronic inflammation can increase the risk of developing tumor processes in the affected organs.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends paying attention to important aspects of health care and gumma prevention. According to him, it is necessary to:
- Conduct regular preventive examinations, especially for people at risk;
- Avoid unprotected sex and discuss health issues with partners;
- Monitor your physical and psychological state, as this affects the immune response.
- At the first symptoms, immediately consult a doctor and do not delay diagnosis to avoid serious complications.
Following these recommendations will help to identify the disease in a timely manner and prevent its spread.
